RetinUp Podcast

RetinUp Podcast, LLC

FDA

Cencora

Geographic Atrophy

Biosimilars In Retina

Ultra-Wide Field Imaging

Retina

Outlook Therapeutics

Photobiomodulation

Glp-1s In Retinal Disease

Government Shutdown

Vit-Buckle Society

Optos

Angiogenesis 2026

Genentech

Clinical Trials At the Summit

Lensone

Orbis International

United States

Gene Therapy

Norlase

RetinUp is a podcast exploring the latest in retina science and ophthalmology. Hosted by John Kitchens, MD, and Scott Krzywonos, each episode features expert insights, research breakthroughs, and practical discussions designed for ophthalmologists, retina specialists, and vision science researchers.

4 ratings

Publishes	Twice monthly	Episodes	28	Founded	10 months ago
Number of Listeners		Categories	MedicineHealth & FitnessTechnology

Listen to this Podcast

Guests Hosts Charts Talking Points

Latest Episodes

Jay Duker, MD, on LUGANO and What Comes Next for Duravyu and EyePoint | Plus, Miles Harper on Successful and Failed OR Innovations

Jay S. Duker, MD, President & CEO of EyePoint Pharmaceuticals, joins John and Scott to parse the LUGANO Phase 3 topline data — just three days after release. He walks through Duravyu's MOA, what the nine outlier patients in the study actually represe... more

20 Aug 2026 • 41 min

Breaking News: EyePoint's Phase 3 Topline Data Release

Breaking news: EyePoint Pharmaceuticals announced LUGANO Phase 3 topline data this morning. Duravyu, an investigational sustained-release TKI for wet AMD, did not meet its primary non-inferiority endpoint in the full dataset — confounded by nine pati... more

17 Aug 2026 • 8 min

Oncology's Biosimilar Lessons for Retina | Plus, Moving to a New OR

The companion piece to RetinUp’s previous episode on biosimilars is here, featuring an oncologist who has lived through biosimilar disruption for the past decade. Stephen "Fred" Divers, MD, CMO of the American Oncology Network, joins John and Scott t... more

13 Aug 2026 • 29 min

Outlook CEO Bob Jahr on the Lytenava Launch | Plus, Miles Harper on Being Connective Tissue for Industry Innovation

Bob Jahr, President & CEO of Outlook Therapeutics, joins John and Scott for one of his first interviews since the Lytenava (bevacizumab-vikg) FDA approval on July 24, 2026. He walks through the long road to approval — three complete response letters,... more

30 Jul 2026 • 22 min

Key Facts

Accepts Guests

Accepts Sponsors

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Retina SynthesisRetina Synthesis

New Retina Radio by EyetubeRetina Today

Straight From The Cutter's Mouth: A Retina PodcastJayanth Sridhar

MedEdTalks - OphthalmologyVindico Medical Education

All-In with Chamath, Jason, Sacks & FriedbergAll-In Podcast, LLC

Recent Guests

Bob Jahr

President and CEO of Outlook Therapeutics

Outlook Therapeutics

Episode: Outlook CEO Bob Jahr on the Lytenava Launch | Plus, Miles Harper on Being Connective Tissue for Industry Innovation

Miles Harper

Consultant/Advisor in ophthalmology ecosystem

Independent

Episode: Outlook CEO Bob Jahr on the Lytenava Launch | Plus, Miles Harper on Being Connective Tissue for Industry Innovation

Dr. Devon Ghodasra

Partner at Southeastern Retina Associates; retina specialist discussing biosimilars

Southeastern Retina Associates

Episode: Devon Ghodasra, MD, on Biosimilars in Practice | Plus Vas Sadda, MD, on Ultra-Widefield Imaging for a Peripheral Detachment

Dr. Vas Sadda

Professor of Ophthalmology; expert in ultra-widefield imaging

Doheny Eye Institute and UCLA

Episode: Devon Ghodasra, MD, on Biosimilars in Practice | Plus Vas Sadda, MD, on Ultra-Widefield Imaging for a Peripheral Detachment

Jorge Fortun

Practices at Bascom Palmer Eye Institute Palm Beach

Bascom Palmer Eye Institute

Episode: Jorge Fortun, MD, on Patient Communication, Palm Beach Practice, & ASRS Preview

Frank Brodie

Assistant Professor of Ophthalmology, UCSF; co-inventor of LensOne

UCSF

Episode: Hunter Cherwek, MD, on Orbis International | Plus Frank Brodie, MD, on LensOne & the GOLDEN GATE Trial

Hunter Cherwek

Vice President, Clinical Services and Technologies, Orbis International

Orbis International

Episode: Hunter Cherwek, MD, on Orbis International | Plus Frank Brodie, MD, on LensOne & the GOLDEN GATE Trial

John Miller

One of the course directors at Mass Eye and Ear; leader of the Mass Eye and Ear Vitrectomy Course

Mass Eye and Ear

Episode: The Future of Bevacizumab | Plus John Miller, MD, on the Mass Eye and Ear Vitrectomy Course | Encelto for MacTel2

Arshad Khanani

Director of Clinical Research at Sierra Eye Associates; Founder and Meeting Co-Chair of Clinical Trials at the Summit

Sierra Eye Associates; Clinical Trials at the Summit

Episode: GLOBE Project & FDA Uncertainty | Arshad Khanani, MD, MA, on Clinical Trials at the Summit | Plus MacTel Image of the Month

Hosts

John Kitchens

Host of RetinUp; long-running presenter with a focus on retina science and ophthalmology.

Scott Krzywonos

Co-host with a background in retina practice and industry-facing discussions.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts	#224	Australia/Health & Fitness/Medicine
Apple Podcasts	#206	Indonesia/Health & Fitness/Medicine

Talking Points

Recent interactions between the hosts and their guests.

Outlook CEO Bob Jahr on the Lytenava Launch | Plus, Miles Harper on Being Connective Tissue for Industry Innovation

Q: Can you walk us through what a complete response letter is and its implications?

A CRL is issued when the FDA cannot approve a submission and outlines missing elements or questions, including data interpretation, endpoints, safety, efficacy, or manufacturing. It often leads to further meetings with the FDA to clarify next steps and the path to approval.

Devon Ghodasra, MD, on Biosimilars in Practice | Plus Vas Sadda, MD, on Ultra-Widefield Imaging for a Peripheral Detachment

Q: What determines which biosimilars you stock and promote in your practice?

Reliability and manufacturer support are key, including patient assistance programs, copay support, and the ability to work with our practice rather than impose payer-driven constraints. We prefer options that allow physician and patient autonomy.

Devon Ghodasra, MD, on Biosimilars in Practice | Plus Vas Sadda, MD, on Ultra-Widefield Imaging for a Peripheral Detachment

Q: What have been the biggest hiccups when adopting biosimilars, and how did you address them?

Billing and reimbursement are the major hurdles, especially around queue codes and temporary codes during transitions. We prepared billing staff, aligned on pre-switch payer coverage, and chose biosimilars with established codes to smooth the process.

Devon Ghodasra, MD, on Biosimilars in Practice | Plus Vas Sadda, MD, on Ultra-Widefield Imaging for a Peripheral Detachment

Q: How do you introduce a biosimilar to a retina practice?

We start with upfront education, a concise script for patients, and a phased rollout beginning with less complex cases, while ensuring the science is explained and trusted by both clinicians and patients.

The Future of Bevacizumab | Plus John Miller, MD, on the Mass Eye and Ear Vitrectomy Course | Encelto for MacTel2

Q: How does Encelto work and why is it significant for MacTel2 patients?

Encelto is a cell-based therapy that provides CNTF-producing cells in a capsule implanted in the eye, potentially offering lifelong treatment for MacTel2 and delaying photoreceptor death, which could significantly affect patient quality of life.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About RetinUp Podcast

What is RetinUp Podcast about and what kind of topics does it cover?

This show consistently covers advanced retina science, ophthalmology practice, and industry dynamics, with a strong emphasis on new therapies, clinical trial findings, and technology that shapes patient care. Across episodes, listeners encounter high-level discussions of cell and gene therapies, imaging innovations, surgical tech, payer and reimbursement challenges, and the economics of retina practice. A notable strength is the blend of technical depth from clinicians and researchers with practical angles on adoption, policy, and access, making it useful for physicians, researchers, and executives involved in retina care and ophthalmology technology. A recurring edge is the involvement of industry stakeholders and professional societies, w... more

Where can I find podcast stats for RetinUp Podcast?

Rephonic provides a wide range of podcast stats for RetinUp Podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to RetinUp Podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does RetinUp Podcast get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for RetinUp Podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for RetinUp Podcast?

Rephonic provides comprehensive predictive audience data for RetinUp Podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does RetinUp Podcast have?

To see how many followers or subscribers RetinUp Podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to RetinUp Podcast?

These podcasts share a similar audience with RetinUp Podcast:

1. Retina Synthesis
2. New Retina Radio by Eyetube
3. Straight From The Cutter's Mouth: A Retina Podcast
4. MedEdTalks - Ophthalmology
5. All-In with Chamath, Jason, Sacks & Friedberg

How many episodes of RetinUp Podcast are there?

RetinUp Podcast launched 10 months ago and published 28 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact RetinUp Podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for RetinUp Podcast?

Rephonic pulls ratings and reviews for RetinUp Podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for RetinUp Podcast?

Rephonic provides full transcripts for episodes of RetinUp Podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on RetinUp Podcast?

Recent guests on RetinUp Podcast include:

1. Bob Jahr
2. Miles Harper
3. Dr. Devon Ghodasra
4. Dr. Vas Sadda
5. Jorge Fortun
6. Frank Brodie
7. Hunter Cherwek
8. John Miller

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days